DermaGen AB intends to develop novel antimicrobial peptides and formulations for the treatment and prevention of bacterial and fungal infections. The company will initially focus on topical applicatio...

Associate Professor Anja Jensen from the Department of Medical Microbiology and Immunology at University of Copenhagen has received a grant of USD 400,000 from the Howard Hughes Medical Institute. ...

Associate Professor Milena Penkowa from the Medical Faculty at University of Copenhagen has received a private donation of USD 900,000 towards her research into diseases of the brain. Milena Pe...

Associate Professor Ole Lund from the Centre for Biological Sequence Analysis, CBS, at the Technical University of Denmark has received a grant of USD 1.2 million from the EU. The grant will go toward...

Hans Skovgaard Poulsen, MD, DMSci, and his research team from Copenhagen University Hospital have developed an in vitro gene therapy against small cell lung cancer. If the treatment is effective in mi...

7TM Pharma has expanded its investor base with the inclusion of Johnson & Johnson Development Corporation, JJDC. JJDC's investment in the company, combined with investments from current investors ...

AstraZeneca and UK-based Astex Therapeutics Limited have announced a new alliance for the discovery, development and commercialization of novel small molecule inhibitors of Protein Kinase B, PKB, for ...

AstraZeneca has entered into an exclusive global licensing and research collaboration agreement with US-based Avanir Pharmaceuticals for the discovery, development and commercialisation of Reverse Cho...

AstraZeneca and Schering AG, Germany, have entered into a research collaboration and licensing agreement in the area of Selective Glucocorticoid Receptor Agonists, SEGRAs, which represent a new class ...

Bavarian Nordic A/S has initiated a Phase II trial to investigate the safety and immunogenicity of IMVAMUNE in HIV infected subjects. The trial, involving 150 volunteers, being conducted at five sites...

DakoCytomation A/S and US-based Clarient Inc. have jointly announced the signing of a five-year Distribution and Development Agreement that allows DakoCytomation to distribute Clarient's digital cellu...

DiLab AB in Lund has signed a distributor agreement with Japanese company Bio Research Center for distribution of its AccuSampler products in Japan. Japan is one of the largest markets in preclinical ...

CMC Biopharmaceuticals A/S has expanded its European Manufacturing Authorisation to include in-market supply of biopharmaceuticals. The approval follows last year's approval of CMC's new state...

Gambro AB will strengthen its global haemodialysis, HD, business through a distribution and promotion agreement with Baxter. Under the terms of the agreement Baxter will distribute and promote Gambro&...

Genmab A/S and Swiss-based Serono have announced an agreement under which Genmab has granted Serono exclusive worldwide rights to develop and commercialise Genmab's HuMax-CD4. HuMax-CD4 is a fully hum...

Genmab A/S has initiated a Phase II study with HuMax-CD20 to treat patients with active rheumatoid arthritis, RA, who have failed one treatment with one or more disease modifying anti-rheumatic drugs,...

MediCult A/S and its Italian distributor CGA Strumenti Scientifici, S.p.A have agreed to form a new sales and distribution company for in vitro fertilisation, IVF, products in Italy. MediCult will own...

MIP Technologies AB has announced the completion of another round of financing totalling USD 4 million. Catella Healthcare Investments AB, a new investor, was responsible for the majority of the inves...

Nanosep AB has received a US patent for a cost-effective technique for separation of molecules that is an important step within proteomics. The technique is applicable on existing equipment in the res...

Pharmexa A/S has entered into a global, non-exclusive license to use Biogen Idec's Provax adjuvant in Pharmexa's products. The parties have agreed not to disclose the commercial terms of the l...

Symphogen A/S has entered into a patent license agreement with UK-based Cambridge Antibody Technology, CAT. Under the terms of the agreement, Symphogen is granted a license to use CAT´s antibod...

TopoTarget A/S and NeuroSearch A/S have expanded their collaboration by signing a development and licensing agreement regarding preclinical and clinical development of the NeuroSearch compound NSD-551...

TopoTarget A/S has received a USD 4.8 million milestone payment from US-based CuraGen Corporation as the ongoing Phase II clinical trial of PXD101 in the treatment of the serious blood cancer known as...

Swedish CRO Trial Form Support International, TFS, AB has acquired Clinical Data Care, based in Lund, Sweden. The acquisition makes TFS the largest CRO in Scandinavia and one of the largest in Europe....

Zealand Pharma A/S has announced the completion of the second stage of its C-financing round of USD 15.8 million, bringing the total financing to USD 34 million. The financing was completed based on Z...